09/22/2026
This is what we need to continue to progress DeltaRex-G. Aldoxorubicin, a chemo therapy drug owned by Gemini Therapeutics, is working its way back to the market. It has lesser side effects in the heart, unlike Doxorubicin. DeltaRex-G has had minimal to no side effects since 2004, yet the cost from the manufacturer makes it almost impossible for the patient. DeltaRex-G also is safe to use for anyone and doesn’t require masks or double flushing! Why were these drugs tabled? Anyone want to guess?
This week saw the launch of the RTW Institute, the non-profit advocacy arm of the biotech investment firm RTW. The Institute promotes dialogue between the various stake holders in the rare space, and is pushing for greater collaboration from all the groups that are a part of it. They're hoping to fo...